Impact of SARS-CoV-2 on lung cancer patient under immunotherapy Cover

.blurhash-client-img { display: none !important; }

Impact of SARS-CoV-2 on lung cancer patient under immunotherapy

Volume 71 (2022): Issue 2 (September 2022)

By: Rinedy Mondonga Lisumbu, Aida-Andreea Fănică, Ioana Eliza Gurzu and Florin Dumitru Mihălțan

Open Access

|Oct 2023

Authors

Rinedy Mondonga Lisumbu

rilis1991@gmail.com

Institutul Național de Pneumoftiziologie “Marius Nasta”, Departement de Pneumologie, Section III, București, Romania

Aida-Andreea Fănică

Institutul Național de Pneumoftiziologie “Marius Nasta”, Departement de Pneumologie, Section III, București, Romania

Ioana Eliza Gurzu

Institutul Național de Pneumoftiziologie “Marius Nasta”, Departement de Pneumologie, Section III, București, Romania

Florin Dumitru Mihălțan

Institutul Național de Pneumoftiziologie “Marius Nasta”, Departement de Pneumologie, Section III, București, Romania

Universitatea de Medicină și Farmacie “Carol Davila”, București, Romania

DOI: https://doi.org/10.2478/pneum-2023-0027 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993

Journal RSS Feed

Language: English

Page range: 89 - 97

Published on: Oct 17, 2023

Published by: Romanian Society of Pneumology

In partnership with: Paradigm Publishing Services

Publication frequency: Volume open

Keywords:

bronchopulmonary cancer,

Related subjects:

Clinical medicine,

Internal medicine,

Clinical medicine, other

© 2023 Rinedy Mondonga Lisumbu, Aida-Andreea Fănică, Ioana Eliza Gurzu, Florin Dumitru Mihălțan, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 71 (2022): Issue 2 (September 2022)Next article